Bio-Rad Laboratories, Inc. Announces Commencement of Exchange Offer of Its 8.00% Senior Subordinated Notes Due 2016 for Registered Notes
(PressMethod) - Bio-Rad Laboratories, Inc. (NYSE:BIO - News) and (NYSE:BIO.B - News), a multinational manufacturer and distributor of life science research and clinical diagnostics products, today announced that it has commenced a registered exchange offer to exchange up to $300 million aggregate principal amount of its 8.00% Senior Subordinated Notes due 2016 which have been registered under the Securities Act of 1933, as amended (the "Exchange Notes"), for any and all of its outstanding 8.00% Senior Subordinated Notes due 2016 which were issued in a private placement (the "Private Notes"). CONTACT INFORMATION Email Us http:// ### Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PressMethod. We will be unable to assist you with your inquiry. PressMethod disclaims any content contained in these release. |